Proxy Votes Now

Home › Funds › DF Tactical Momentum VIT

DF Tactical Momentum VIT proxy voting record 2025-2026

Fund family: Northern Lights Variable Trust · Filed by Northern Lights Variable Trust (CIK 1352621) · SEC series S000016887

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 516 with, 35 against, 0 abstentions (not counted as with management). Shareholder proposals: 14 FOR, 21 AGAINST, 0 abstained, by the filing’s own vote-source field.

No item-level comparison with other Northern Lights Variable Trust funds is possible: fewer than three other funds of the family voted in 2025-2026.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 100.0% of this fund’s 551 such votes could be given a sector.

SectorVotesAgainst managementShare
Finance12864.7%
Technology9966.1%
Industrials8955.6%
Health Care8766.9%
Telecommunications5459.3%
Consumer Discretionary30310.0%
Utilities1915.3%
Energy17211.8%
Basic Materials1516.7%
Real Estate1300.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3820
Say-on-Pay410
Audit-related390
Corporate Governance3717
Compensation180
Capital Structure100
Environment or Climate99
Other Social Issues77
Extraordinary Transactions60
Human Rights or Human Capital/workforce11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Western Digital CorporationNovember 20, 2025$4M110
Cardinal Health, Inc.November 5, 2025$2M140
Target CorporationJune 10, 2026$2M183
Cboe Global Markets, Inc.May 14, 2026$2M151
Principal Financial Group, Inc.May 19, 2026$2M80
Merck & Co., Inc.May 26, 2026$2M183
Eli Lilly and CompanyMay 4, 2026$2M102
DexCom, Inc.May 27, 2026$2M140

Notable votes against management

MeetingCompanyProposalFundMgmt
June 10, 2026Target CorporationShareholder proposal requesting policy requiring the Board Chair to be an independent director. Shareholder proposalForAgainst
June 10, 2026Target CorporationShareholder proposal requesting a report on presence of pesticides in Target's private label brands. Shareholder proposalAgainstFor
May 14, 2026Cboe Global Markets, Inc.Stockholder proposal regarding shareholder right to act by written consent. Shareholder proposalForAgainst
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
April 23, 2026Johnson & JohnsonIndependent Board Chair Shareholder proposalAgainstFor
February 24, 2026Apple Inc.A shareholder proposal entitled "China Entanglement Audit" Shareholder proposalAgainstFor
May 27, 2026Exxon Mobil CorporationIndependent Chair, a proposal overwhelmingly defeated on 16 separate occasions since 2000 Shareholder proposalAgainstFor
May 27, 2026Exxon Mobil CorporationProposal requesting Company to modify its Voluntary Retail Voting Program to provide multiple options not aligned with the Board's recommendations Shareholder proposalForAgainst
May 2, 2026Cincinnati Financial CorporationA nonbinding shareholder proposal, if properly presented at the meeting. Shareholder proposalForAgainst

Search this fund’s votes by company

552 ballot items at 41 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, DF Tactical Momentum VIT voted at 41 shareholder meetings of 40 companies, on 552 ballot items in all. Where management made a recommendation, the fund followed it on 93.6% of the items and voted against it 35 times. Its most frequent area of disagreement was corporate governance (17 of its votes against management). It voted on 35 shareholder proposals.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.